Literature DB >> 15122748

Screening in liver disease: report of an AASLD clinical workshop.

Paul C Adams1, Michael J Arthur, Thomas D Boyer, Laurie D DeLeve, Adrian M Di Bisceglie, Mark Hall, Theodore R Levin, Dawn Provenzale, Leonard Seeff.   

Abstract

This report summarizes an AASLD Clinical Workshop that was presented at Digestive Diseases Week 2003 on screening in liver diseases. As newer diagnostic tests become available, many liver diseases and complications of liver disease can be detected at an early asymptomatic stage. In many cases, early detection can lead to earlier treatment and an improved outcome. However, screening for liver diseases in asymptomatic persons has the potential for adverse consequences, including discrimination and stigmatization. The cost of screening programs is significant, and access to screening tests varies in different countries. Future screening programs require careful planning and implementation to balance the benefits, risks, and cost-effectiveness. This review outlines the concepts of screening and their application to a broad range of liver diseases.

Entities:  

Mesh:

Year:  2004        PMID: 15122748     DOI: 10.1002/hep.20169

Source DB:  PubMed          Journal:  Hepatology        ISSN: 0270-9139            Impact factor:   17.425


  15 in total

Review 1.  Review.

Authors:  Eric R Kallwitz
Journal:  Gastroenterol Hepatol (N Y)       Date:  2006-08

Review 2.  Platelet count, spleen length, and platelet count-to-spleen length ratio for the diagnosis of oesophageal varices in people with chronic liver disease or portal vein thrombosis.

Authors:  Agostino Colli; Juan Cristóbal Gana; Jason Yap; Thomasin Adams-Webber; Natalie Rashkovan; Simon C Ling; Giovanni Casazza
Journal:  Cochrane Database Syst Rev       Date:  2017-04-26

Review 3.  Nonalcoholic fatty liver disease.

Authors:  Leon A Adams; Paul Angulo; Keith D Lindor
Journal:  CMAJ       Date:  2005-03-29       Impact factor: 8.262

4.  Medical Care of the Patient With Compensated Cirrhosis.

Authors:  Jorge L Herrera; Reynaldo Rodríguez
Journal:  Gastroenterol Hepatol (N Y)       Date:  2006-02

Review 5.  Capsule endoscopy for the diagnosis of oesophageal varices in people with chronic liver disease or portal vein thrombosis.

Authors:  Agostino Colli; Juan Cristóbal Gana; Dan Turner; Jason Yap; Thomasin Adams-Webber; Simon C Ling; Giovanni Casazza
Journal:  Cochrane Database Syst Rev       Date:  2014-10-01

Review 6.  Screening in liver disease.

Authors:  Paolo Del Poggio; Marzio Mazzoleni
Journal:  World J Gastroenterol       Date:  2006-09-07       Impact factor: 5.742

Review 7.  [Early diagnosis of liver diseases].

Authors:  M M Dollinger; L Fechner; W E Fleig
Journal:  Internist (Berl)       Date:  2005-04       Impact factor: 0.743

8.  Surveillance for hepatocellular carcinoma improves survival in Asian-American patients with hepatitis B: results from a community-based clinic.

Authors:  Myron J Tong; Hai-En Sun; Carlos Hsien; David S K Lu
Journal:  Dig Dis Sci       Date:  2009-12-04       Impact factor: 3.199

Review 9.  The epidemiology of hepatitis C infection in the United States.

Authors:  Vinod K Rustgi
Journal:  J Gastroenterol       Date:  2007-07-25       Impact factor: 7.527

10.  Hepatocellular carcinoma in Native South Asian Pakistani population; trends, clinico-pathological characteristics & differences in viral marker negative & viral-hepatocellular carcinoma.

Authors:  Amna Subhan Butt; Saeed Hamid; Ashfaq Ahmad Wadalawala; Mariam Ghufran; Ammar Asrar Javed; Omer Farooq; Bilal Ahmed; Tanveer Ul Haq; Wasim Jafri
Journal:  BMC Res Notes       Date:  2013-04-08
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.